Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.360
-0.415 (-10.99%)
At close: Dec 5, 2025, 4:00 PM EST
3.340
-0.020 (-0.60%)
After-hours: Dec 5, 2025, 7:40 PM EST
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $82.47 million as of December 5, 2025. Its market cap has decreased by -69.95% in one year.
Market Cap
82.47M
Enterprise Value
-28.81M
1-Year Change
-69.95%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $82.47M, a decrease of -53.34%. That is a compound annual growth rate of -42.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 82.47M | -66.32% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |